Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc. (ACAD) — Form 8-K: Current report
About this filing
Acadia Pharmaceuticals Inc. (ACAD) filed an 8-K on Oct 23, 2026 reporting an executive or director change or pay arrangement (Item 5.02).
Key facts
- Item 5.02 · Executive or director change or pay arrangement
More ACAD filings
- 4
Filed Oct 30, 2026
- 8-K
Filed Sep 24, 2026
- 8-K
Filed Sep 11, 2026
- 4
Filed Aug 7, 2026
- SC 13G
Filed Aug 7, 2026
- 144
Filed Aug 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.